Clinical Trial

The Effect of Education Based on Orem's Self-Care Deficit Theory and Tele-Monitoring on Rational Drug Use in Haemodialysis Patients

Study acronym: Haemodialysis
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated November 14, 2024 (before its estimated December 15, 2024 completion). Its status may not reflect the trial's current state.
Summary
Patients with chronic kidney disease may show altered pharmacokinetic and pharmacodynamic response to many drugs compared to patients with normal renal function. Therefore, effective and safe drug use is difficult in patients with chronic kidney disease and especially in dialysis patients. In addition, some drugs may have nephrotoxic effects by causing further deterioration in renal function, especially in high-risk renal patients. Prevention of problems related to drug use in haemodialysis patients will be possible with rational drug use (RUD). RDM is defined as 'the set of rules to be followed in order for patients to take medicines in accordance with their clinical needs, in doses that meet their personal needs, in sufficient time, at the lowest cost to themselves and the society'. Rational drug use has become an increasingly important concept today. In studies investigating rational drug use, problems such as incorrect use of drugs, prescribing more drugs than necessary, unnecessary injection recommendation/administration, unnecessary antibiotic consumption, and unnecessary use of expensive drugs have been identified. As a result of incorrect drug use, poisoning or decreased sensitivity to drugs are observed.
Trial Details
NCT Number NCT06689228
Lead Sponsor Akdeniz University
Conditions Haemodialysis
Enrollment 70 participants
Start Date 2024-11-15
Primary Completion 2024-12-15 (estimated)
Study Completion 2025-01-15 (estimated)
Updated on ClinicalTrials.gov 2024-11-14